Banking on Microbiota

Kaneka’s white paper covers how and why the search for microbiomes untouched by westernized diets and lifestyle was conducted 20 years ago. Today, they are going through their library of hundreds of bacteria strains and identifying the strain’s mechanisms of action. Once identified the mechanism of action is verified through vitro, in vivo and human clinical trials to identify specific health benefits and health claims for its probiotic products. This paper includes a summary of the 2021 clinical trial on the baby colic probiotic formulation and a case study about the intensive G.I probiotic formulation.

Request Free!